Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC

NCT00181532 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Carcinoma

Interventions

DRUG: Celecoxib

Sponsor

Maastricht Radiation Oncology

Collaborators

[object Object]